ARRY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ARRY is not a good buy right now for a Beginner focused on long-term investing, even with $50,000-$100,000 available. The stock has near-term value interest and some bullish analyst targets, but the current technical setup is still weak and there is no strong proprietary buy signal today. If the investor is impatient and wants to act now, this is more of a hold than a fresh buy.
ARRY closed at 7.02, just above the prior close of 6.97, but the broader setup remains bearish. MACD histogram is negative and still expanding lower, which shows downside momentum is not yet fully exhausted. RSI_6 at 31.98 is near oversold territory but not a clear reversal signal. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5, indicating the longer-term trend is still down. Price is sitting near S1 support at 6.927, with resistance at 7.668 pivot and then 8.409 R1. The stock trend model also points to weak forward performance, with a -2.78% expectation over the next month.
Analysts have recently turned more constructive on the name, with Goldman Sachs, JPMorgan, and UBS all raising price targets on the Q1 beat and stronger order book commentary. UBS highlighted strong order book growth and healthy U.S. utility-scale solar development. Goldman noted better-than-expected revenue and margins driven by stronger domestic mix and cost actions. These updates support a recovery thesis over time.
No news was reported in the last week, so there is no fresh event-driven catalyst. The technical trend is still bearish, and the stock remains below key resistance. Some recent analyst actions were only equal-weight/hold-like rather than outright bullish, and the clean energy sector still appears uneven. Hedge funds and insiders are neutral, so there is no strong buying signal from smart money. No recent politician or influential figure trading was reported, and no recent congress trading data is available.
Latest quarter financials were not fully provided, but the available analyst commentary says the company reported a solid Q1 beat with revenue and margins above consensus. The beat was driven by stronger domestic mix, cost actions, and one-time benefits, and another note highlighted strong order book growth. This suggests improving operating momentum in the latest reported quarter, although the incomplete financial snapshot prevents a deeper assessment. Latest quarter season: Q1 2026.
Recent analyst sentiment has improved modestly. Goldman Sachs, JPMorgan, and UBS raised price targets and kept Buy/Overweight ratings. Morgan Stanley also raised its target but only kept Equal Weight, while earlier April updates from Susquehanna, Deutsche Bank, and Barclays were more cautious with Neutral/Hold-like ratings and lower targets. Wall Street’s pros see improving Q1 execution, order book growth, U.S. solar demand, and potential margin support. The cons view is that the stock still faces a tough technical backdrop, and several firms remain cautious on valuation and sector execution.
